Xtrackers MSCI USA UCITS ETF 2C - EUR Hedged is a equity ETF from Xtrackers tracking the MSCI USA index through physical replication. Domiciled in Ireland and launched in 2018, the fund manages about 626 M € and charges a TER of 0.12% — 12 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
Xtrackers MSCI USA UCITS ETF 2C - EUR Hedged competes with 13 other products on the same index (MSCI USA): it ranks 10th by fund size and 11th by ongoing cost, with a TER of 0.12% against a group median of 0.09%. It has been listed since 2018, 8 years of track record.
On a €10,000 investment the TER costs 12 € a year. The cheapest of the group is Xtrackers MSCI USA UCITS ETF 1C at 0.03%, or 3 € on the same amount: a difference of 9 € every year, roughly 90 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 35.4% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR and is a currency-hedged share class: the hedge aims to neutralise the effect of the underlying currencies against the reference currency, at an implicit cost that varies with interest-rate differentials.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| NVIDIA Corporation | 7.1% |
| Apple Inc. | 6.6% |
| Microsoft Corporation | 4.1% |
| Amazon.com Inc | 3.6% |
| Alphabet Inc Class A | 3.2% |
| Broadcom Inc | 2.6% |
| Alphabet Inc Class C | 2.5% |
| Micron Technology Inc | 2.0% |
| Meta Platforms Inc. | 1.9% |
| Tesla Inc | 1.8% |
| Borsa Italiana | XD9E | EUR |
| XETRA | XD9E | EUR |
| Francoforte | XD9E | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.